Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.
2.

Cognitive and brain imaging measures of Alzheimer's disease.

Cutler NR.

Neurobiol Aging. 1988 Jan-Feb;9(1):90-2.

PMID:
3260013
3.

[Alzheimer's dementia. Advances in diagnosis and therapy].

[No authors listed]

MMW Fortschr Med. 2003 May 26;145 Suppl 2:20-1. German. No abstract available.

PMID:
14579478
4.

PET imaging in Alzheimer's disease.

Besson JA, Crawford JR, Evans NT, Gemmell HG, Roeda D.

J R Soc Med. 1992 Apr;85(4):231-4. No abstract available.

5.

Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.

Rinne JO, Kaasinen V, Järvenpää T, Någren K, Roivainen A, Yu M, Oikonen V, Kurki T.

J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):113-5.

6.
7.

Cognitive and brain imaging measures of Alzheimer's disease.

Riege WH, Metter EJ.

Neurobiol Aging. 1988 Jan-Feb;9(1):69-86. Review.

PMID:
3288895
8.

[Clinical diagnosis of Alzheimer's disease].

Kurz A, Haupt M, Romero B, Zimmer R, Lauter H.

Dtsch Med Wochenschr. 1988 Nov 4;113(44):1723-7. German. No abstract available.

PMID:
3263263
9.

A PET study of the functional neuroanatomy of writing impairment in Alzheimer's disease. The role of the left supramarginal and left angular gyri.

Penniello MJ, Lambert J, Eustache F, Petit-Taboué MC, Barré L, Viader F, Morin P, Lechevalier B, Baron JC.

Brain. 1995 Jun;118 ( Pt 3):697-706.

PMID:
7600087
10.

Detection of prodromal Alzheimer's disease.

Mortimer JA, Petersen RC.

Ann Neurol. 2008 Nov;64(5):479-80. doi: 10.1002/ana.21552. No abstract available.

PMID:
19067352
11.

MR and PET vie in diagnosis of Alzheimer's disease.

Lowers J.

Diagn Imaging (San Franc). 2000 Nov;22(11):113-6. No abstract available.

PMID:
11148954
12.
13.

Neuropsychological assessment in Alzheimer's disease.

Storandt M.

Exp Aging Res. 1991 Summer;17(2):100-1. No abstract available.

PMID:
1794378
14.

[Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease].

Arbizu J, Larumbe R, Gámez C, Martí J, Martínez-Lage J, Richter J.

Rev Esp Med Nucl. 1999 Aug;18(4):252-60. Spanish.

15.

Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease.

Ballard C, O'Brien J, Tovee M.

J Neurol Neurosurg Psychiatry. 2002 May;72(5):565-6. No abstract available.

16.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

PMID:
16854944
17.

Korean Addenbrooke's Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia.

Kwak YT, Yang Y, Kim GW.

Geriatr Gerontol Int. 2010 Oct;10(4):295-301. doi: 10.1111/j.1447-0594.2010.00624.x. Epub 2010 May 17.

PMID:
20497240
18.

[Cortical and subcortical dementia: where is the difference?].

Gonźalez Salvador T.

Med Clin (Barc). 2000 Apr 22;114(15):577-8. Spanish. No abstract available.

PMID:
10846677
19.

Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.

Clin Neurophysiol. 2005 Feb;116(2):364-75.

PMID:
15661114
20.

Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI.

Arch Neurol. 1986 Sep;43(9):882-5.

PMID:
3488728

Supplemental Content

Support Center